Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Globus Medical Inc (NYSE: GMED) closed the day trading at $55.82 down -22.96% from the previous closing price of $72.46. In other words, the price has decreased by -$22.96 from its previous closing price. On the day, 10.89 million shares were traded.
Ratios:
For a better understanding of GMED, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.46. For the most recent quarter (mrq), Quick Ratio is recorded 2.72 and its Current Ratio is at 4.45. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 02, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $83 to $100.
Wells Fargo Upgraded its Equal Weight to Overweight on August 07, 2024, whereas the target price for the stock was revised from $60 to $78.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 28 ’25 when RHOADS ANN D sold 7,500 shares for $78.68 per share. The transaction valued at 590,100 led to the insider holds 35,384 shares of the business.
RHOADS ANN D bought 7,500 shares of GMED for $590,000 on Feb 28 ’25. On Jan 10 ’25, another insider, Pfeil Keith W, who serves as the COO, CFO of the company, sold 14,167 shares for $88.29 each. As a result, the insider received 1,250,770 and left with 0 shares of the company.
Valuation Measures:
As of this moment, Globus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.75, and their Forward P/E ratio for the next fiscal year is 15.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 1.85.
Stock Price History:
Over the past 52 weeks, GMED has reached a high of $94.93, while it has fallen to a 52-week low of $60.85. The 50-Day Moving Average of the stock is -23.20%, while the 200-Day Moving Average is calculated to be -27.44%.
Shares Statistics:
A total of 112.93M shares are outstanding, with a floating share count of 111.93M. Insiders hold about 17.30% of the company’s shares, while institutions hold 82.45% stake in the company.
